线粒体移植:对线粒体疾病的有希望的治疗方法
Qiangqiang Jiao1, Li Xiang2, Yuping Chen3
1School of Pharmaceutical Sciences, University of South China, Hengyang, Hunan 410001, China.
International journal of pharmaceutics
|May 4, 2024
概括
线粒体移植疗法 (MTT) 提供了一种新的方法来治疗由线粒体功能障碍引起的疾病,通过用健康的线粒体取代受损的线粒体. 这种疗法在各种危急疾病,包括神经和心血管疾病中表现有前途.
科学领域:
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 线粒体对于细胞的能量生产和生存至关重要.
- 线粒体功能障碍与许多人类疾病有关.
- 目前对线粒体疾病的治疗方法取得的成功有限.
研究的目的:
- 审查线粒体转移的机制和策略.
- 探索线粒体移植疗法 (MTT) 对各种疾病的应用.
- 讨论MTT在临床环境中的挑战和前景.
主要方法:
- 审查关于线粒体转移机制的现有文献.
- 对MTT应用的临床前和临床数据的分析.
- 讨论将MTT转化为广泛的临床使用所面临的挑战.
主要成果:
- 线粒体可以在细胞之间转移,并恢复它们的功能.
- 在动物模型中,MTT在关键疾病 (如中枢神经系统疾病,心血管疾病和癌症) 中表现有前途.
- 对心脏缺血-再输血损伤的早期临床试验显示出令人鼓舞的结果.
结论:
- 线粒体移植疗法为一系列线粒体疾病提供了有前途的治疗策略.
- 需要进行进一步的研究和临床试验,以克服挑战并优化MTT,使患者受益.
- 在关键疾病中,MTT具有显著的潜力,可以改善患者的治疗结果.
更多相关视频
10:35Rapid Isolation And Purification Of Mitochondria For Transplantation By Tissue Dissociation And Differential Filtration
Published on: September 6, 2014
38.2K
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
810
相关概念视频
Tissue Transplantation
360
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
360
Bone Marrow Sampling and Transplants
326
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
326
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
